Filter Results:
(2,466)
Show Results For
- All HBS Web
(5,165)
- People (16)
- News (1,911)
- Research (2,466)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,884)
Show Results For
- All HBS Web
(5,165)
- People (16)
- News (1,911)
- Research (2,466)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,884)
Sort by
- November 2006
- Article
Utilizing List Exchange and Undirected Good Samaritan Donation through 'Chain' Paired Kidney Exchanges
By: Alvin E Roth, Tayfun Sonmez, M. Utku Unver, Francis L. Delmonico and Susan L. Saidman
Roth, Alvin E., Tayfun Sonmez, M. Utku Unver, Francis L. Delmonico, and Susan L. Saidman. "Utilizing List Exchange and Undirected Good Samaritan Donation through 'Chain' Paired Kidney Exchanges." American Journal of Transplantation 6, no. 11 (November 2006): 2694–2705.
- 13 Jun 2017
- First Look
First Look at New Research and Ideas, June 13
case:https://cb.hbsp.harvard.edu/cbmp/product/817088-PDF-ENG Harvard Business School Case 316-112 Health Systems in the Developing World This note offers an approach to the evaluation of health View Details
Keywords: Sean Silverthorne
- June 2024
- Supplement
Legacy Partners (A)
By: Richard S. Ruback and Royce Yudkoff
Instructors should consider the timing of making videos available to students, as they may reveal key case details.
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Health Industry; Health Industry; Health Industry; United States; California
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (A)." Harvard Business School Multimedia/Video Supplement 224-725, June 2024.
- 22 Sep 2003
- Research & Ideas
How Businesses Can Respond to AIDS
"large majority" of Coke's bottlers around the world—which add water, carbonization, and sweeteners, and take care of distribution—are independent bottlers. Bottlers are chosen because they work in local communities. Coke sees... View Details
Keywords: by Martha Lagace
- March 2010
- Supplement
Deworming Kenya: Translating Research into Action (B)
By: Nava Ashraf, Neil Buddy Shah and Rachel Gordon
Karen Levy and her colleague, Margaret Ndanyi, learn the results of their nation-wide effort to rid Kenyan school children of parasitic worm infection. View Details
Ashraf, Nava, Neil Buddy Shah, and Rachel Gordon. "Deworming Kenya: Translating Research into Action (B)." Harvard Business School Supplement 910-027, March 2010.
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
The widespread use of pricing algorithms is reshaping the nature of competition in online markets and potentially driving up the prices of retail goods, according to recent research. These automated, price-adjusting software programs may also be catching the eye of... View Details
- 23 Dec 2014
- First Look
First Look: December 23
with pediatric hospitals in Temple, San Antonio, and Mexico City, and how to structure these partnerships was under active discussion. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/714507-PDF-ENG Harvard Business School Case 514-122 Note on Mobile View Details
Keywords: Carmen Nobel
- October 2013 (Revised April 2015)
- Case
Myomo: Getting Sales in Motion
By: Frank V. Cespedes, Shikhar Ghosh and Matthew Preble
In late 2012, the management team of Myomo, a startup which had designed a unique myoelectric arm brace for patients with dysfunctional arms, was deciding which of the three sales models the company had tested to pursue as its sales strategy going forward. Each model... View Details
Keywords: Technological Innovation; Information Technology; Marketing Strategy; Decision Choices and Conditions; Health Care and Treatment; Business Startups; Sales; Growth and Development Strategy; Health Industry; Health Industry
Cespedes, Frank V., Shikhar Ghosh, and Matthew Preble. "Myomo: Getting Sales in Motion." Harvard Business School Case 814-034, October 2013. (Revised April 2015.)
- 22 Dec 2016
- Op-Ed
The Small Business Administration is a Model for How to Drive Economic Growth
to American innovation and growth. Small businesses are actually the foundation for economic growth and, with that, critical to policy that purports to care about the average American. In fact, if we consider what Americans expect from... View Details
Keywords: by Karen Mills
- November 1997 (Revised May 1999)
- Case
Medical Foods, Inc.
By: Ray A. Goldberg and Tom Clay
Dr. Franklin Lowe is CEO of a new kind of company in a new kind of industry--medical foods. He must select a business model and partners that will help make this a viable business. View Details
Keywords: Business Model; Partners and Partnerships; Business or Company Management; Strategy; Business Startups; Health Care and Treatment; Food; Innovation and Management; Health Industry; Health Industry
Goldberg, Ray A., and Tom Clay. "Medical Foods, Inc." Harvard Business School Case 598-048, November 1997. (Revised May 1999.)
- 03 Apr 2012
- First Look
First Look: April 3
leadership development programs for residents. The authors first present a definition of clinical leadership and highlight evidence that effective frontline clinical leadership improves both clinical outcomes and satisfaction for patients and providers. The authors... View Details
Keywords: Carmen Nobel
- December 2017
- Article
Overall Cost Comparison of Gastrointestinal Endoscopic Procedures with Endoscopist- or Anesthesia-Supported Sedation by Activity-Based Costing Techniques
By: Richard A. Helmers, James A. Dilling, Christopher R. Chaffee, Mark V. Larson, Bradly J. Narr, Derek A. Haas and Robert S. Kaplan
Endoscopic/Colonoscopic procedures are done either with gastroenterologist-administered conscious sedation or with anesthesia-administered sedation with propofol. Anesthesia-administered sedation has medical and patient benefits but is more expensive to administer. We... View Details
Helmers, Richard A., James A. Dilling, Christopher R. Chaffee, Mark V. Larson, Bradly J. Narr, Derek A. Haas, and Robert S. Kaplan. "Overall Cost Comparison of Gastrointestinal Endoscopic Procedures with Endoscopist- or Anesthesia-Supported Sedation by Activity-Based Costing Techniques." Mayo Clinic Proceedings: Innovations, Quality & Outcomes 1, no. 3 (December 2017): 234–241.
- January 2014
- Supplement
Fred Khosravi and AccessClosure (C)
By: Richard Hamermesh and Lauren Barley
On September 11, 2013, the three-judge panel of the U.S. Court of Appeals for the Federal Circuit denied St. Jude's request to rehear an appeal on the "double patenting" ruling for the '439 patent. Further, it removed the injunction threat that was hanging over the... View Details
Keywords: Medical Devices; Vascular Closure Device; Patent Litigation; Patenting; Biomedical Research; Biotechnology; Biotech; Technological Innovation; Patents; Health Care and Treatment; Biotechnology Industry; United States
Hamermesh, Richard, and Lauren Barley. "Fred Khosravi and AccessClosure (C)." Harvard Business School Supplement 814-074, January 2014.
- October 2013 (Revised January 2014)
- Supplement
Fred Khosravi and AccessClosure (B)
By: Richard G. Hamermesh and Lauren Barley
It was January 2013, and Fred Khosravi, chairman of the board of AccessClosure Inc., wondered what the new year had in store for him and AccessClosure, the company he founded in late 2002. Khosravi was cautiously optimistic—the Mountain View, California-based medical... View Details
Keywords: Medical Devices; Vascular Closure Device; Patent Litigation; Patenting; Biomedical Research; Biotechnology; Biotech; Technological Innovation; Patents; Health Care and Treatment; Biotechnology Industry; United States; California
Hamermesh, Richard G., and Lauren Barley. "Fred Khosravi and AccessClosure (B)." Harvard Business School Supplement 814-038, October 2013. (Revised January 2014.)
- April 2011 (Revised October 2011)
- Teaching Note
U.S. Healthcare Reform: International Perspectives (TN)
By: Arthur A. Daemmrich and Elia Cameron
Teaching Note for #710-040 and 711-103. View Details
- 08 Sep 2020
- Sharpening Your Skills
Capitalism Works Better When I Can See What You're Doing
corrupt company. Why American Health Care Needs Its Own SECThe United States needs a health care equivalent of the Securities and Exchange... View Details
Keywords: by Sean Silverthorne
- 01 Dec 2011
- What Do You Think?
Thinking Slow: An Argument for Bureaucracy?
rigidity, unthinking application of age-old rules (vs.) careful reflective thought on matters that need intelligent application of criteria." Just how to promote slow thinking where it is appropriate stimulated an interesting and... View Details
Keywords: by James Heskett
- 02 Mar 2010
- First Look
First Look: March 2
Andrew Huang and the Center had worked with the Taiwan National Health Insurance system to create a pay-for-performance reimbursement program for breast cancer care that has since been adopted by five other... View Details
Keywords: Martha Lagace
- Article
Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users
By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (B)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)